ARTICLE | Clinical News
Davunetide: Additional Phase IIa data
April 5, 2010 7:00 AM UTC
Data from a subset of 18 chronic schizophrenics from a double-blind, U.S. Phase IIa trial showed that intranasal davunetide significantly increased levels of N-acetyl aspartate as measured by magnetic...